GB9521725D0 - Medical treatment - Google Patents

Medical treatment

Info

Publication number
GB9521725D0
GB9521725D0 GBGB9521725.3A GB9521725A GB9521725D0 GB 9521725 D0 GB9521725 D0 GB 9521725D0 GB 9521725 A GB9521725 A GB 9521725A GB 9521725 D0 GB9521725 D0 GB 9521725D0
Authority
GB
United Kingdom
Prior art keywords
medical treatment
medical
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9521725.3A
Other versions
GB2306321A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHILD ANNE
Original Assignee
CHILD ANNE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHILD ANNE filed Critical CHILD ANNE
Priority to GB9521725A priority Critical patent/GB2306321A/en
Publication of GB9521725D0 publication Critical patent/GB9521725D0/en
Publication of GB2306321A publication Critical patent/GB2306321A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9521725A 1995-10-24 1995-10-24 The use of (+)-catechin in the treatment or prophylaxis of connective tissue disorders Withdrawn GB2306321A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9521725A GB2306321A (en) 1995-10-24 1995-10-24 The use of (+)-catechin in the treatment or prophylaxis of connective tissue disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9521725A GB2306321A (en) 1995-10-24 1995-10-24 The use of (+)-catechin in the treatment or prophylaxis of connective tissue disorders

Publications (2)

Publication Number Publication Date
GB9521725D0 true GB9521725D0 (en) 1996-01-03
GB2306321A GB2306321A (en) 1997-05-07

Family

ID=10782794

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9521725A Withdrawn GB2306321A (en) 1995-10-24 1995-10-24 The use of (+)-catechin in the treatment or prophylaxis of connective tissue disorders

Country Status (1)

Country Link
GB (1) GB2306321A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1207862A2 (en) * 1999-06-07 2002-05-29 The University Of Sheffield Arthritis treatment
US7108868B2 (en) * 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US8945518B2 (en) 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
RU2379031C2 (en) * 2002-04-30 2010-01-20 Юниджен Фармасьютиклз, Инк. Preparation of mixture of flavonoids with free b-ring and flavans as therapeutic agent
AU2004228021B2 (en) 2003-04-04 2010-09-02 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
BE1023772B9 (en) 2013-05-17 2017-08-02 Valore COMPOSITION BASED ON A (+) - CATECHIN AND AMINO ACID COMPLEX FOR THE TREATMENT AND PREVENTION OF CANCER

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285964A (en) * 1979-08-30 1981-08-25 Continental Pharma Salts of (+)-catechine, their preparation and use, and compositions containing these salts
US4268517A (en) * 1979-08-30 1981-05-19 Continental Pharma Pharmaceutical composition and therapeutical method for treating degenerative affections of the articular cartilage

Also Published As

Publication number Publication date
GB2306321A (en) 1997-05-07

Similar Documents

Publication Publication Date Title
GB2298440B (en) Well treatment
ZA978450B (en) Medical treatment
AU6913796A (en) Patient treatment apparatus
HUP9901089A3 (en) Medical splint
GB9519033D0 (en) Treatment
GB2303303B (en) Medical treatment
GB9521725D0 (en) Medical treatment
HUP9901448A3 (en) Novel medical use
GB9217124D0 (en) Medical treatment
ZA953237B (en) Medical treatment
GB9526264D0 (en) Medical treatment
GB2307858B (en) Medical treatment
GB9508438D0 (en) Medical treatment
GB9421398D0 (en) Medical treatment
ZA951421B (en) Medical treatment
GB9424728D0 (en) Medical treatment
GB9425164D0 (en) Medical treatment
GB9425773D0 (en) Medical treatment
GB9612330D0 (en) Medical treatment
GB9602728D0 (en) Medical treatment
GB9626265D0 (en) Medical treatment
GB9626859D0 (en) Medical treatment
GB9618375D0 (en) Medical treatment
GB9621327D0 (en) Medical treatment
GB9321793D0 (en) Medical treatment

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)